{'fraction_non_alphanumeric': 0.052772808586762074, 'fraction_numerical': 0.03309481216457961, 'mean_word_length': 5.216666666666667, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Endothelins and membrane potential of vascular smooth muscle of the canine coronary artery.

We investigated the effects of endothelins on the membrane potential of vascular smooth-muscle cells of canine coronary artery, using glass microelectrodes. In tissues with endothelium, endothelin-1 (ET-1), from 10(-12) to 10(-9) M, did not alter the membrane potential. Higher concentrations of the peptide produced sustained depolarization without detectable hyperpolarization. Endothelin-3 (ET-3, 10(-11) to 10(-8) M) did not produce significant membrane hyperpolarization in tissues with endothelium. Prostaglandin F2 alpha (10(-5) M) depolarized the cell membrane by about 6 mV. ET-1 (10(-9) M) did not evoke detectable hyperpolarization in the presence of prostaglandin F2 alpha. In tissues incubated with BQ123 (10(-6) M, a selective ETA-receptor antagonist), which attenuated the depolarization evoked by ET-1, both isopeptides did not produce detectable hyperpolarization. These findings suggest that ET-1 and ET-3 do not evoke the release of endothelium-derived hyperpolarizing factor in the canine coronary artery.